Some previous studies have shown dramatic differences among E2 regulated genes in ER+/PR+ breast cancer cell lines and their cognate xenograft tumors37, while other studies show ~ 40% overlap among genes regulated in cell lines and tumors38. This evidence concerns the gene ESR1 and breast carcinoma.